CA 125 / SERUM

image not found

NABL Cap Accredited 

The CA 125 test measures the level of cancer antigen 125 in serum, which can be elevated in ovarian cancer and certain benign conditions. It is widely used to support diagnosis, monitor treatment response, and detect recurrence in relevant clinical situations. Metropolis Healthcare performs this test using highly sensitive immunoassay technology to ensure accurate and consistent results. When interpreted with clinical findings, this test provides valuable insight for patient management.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,550.00

Sample Type: SERUM

Fasting Not Required


Notes: C0005

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CA 125 antigen levels in serum, performed with reliability by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassay methods to detect and quantify CA 125 accurately.

Who should take this test?
Patients under evaluation for ovarian pathology or those monitoring cancer treatment can benefit at Metropolis Healthcare.

Are elevated CA 125 levels always cancer?
No, Metropolis Healthcare notes that benign conditions like endometriosis or inflammation can also raise CA 125.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs a serum sample.

How is this test used in monitoring?
Metropolis Healthcare uses CA 125 trends to assess treatment response and detect possible recurrence.

Can this test screen healthy women?
Metropolis Healthcare does not recommend it as a general screening test due to limited specificity.

How long does it take to get results?
Metropolis Healthcare provides timely and accurate results to support clinical decision-making.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab